Jønsson, Alexandra Brandt Ryborg
Brodersen, John Brandt
Reventlow, Susanne
Svanholm, Christina
Møller, Anne
Kousgaard, Marius Brostrøm
Funding for this research was provided by:
Novo Nordisk Fonden (NNF16OC0022038)
Article History
Received: 30 August 2023
Accepted: 11 March 2024
First Online: 22 March 2024
Declarations
:
: According to the Danish legislation, “komitéloven” (ExternalRef removed), qualitative research that does not involve human tissue samples, access to patient records, or legal records, and in which participants’ identifiers (i.e. name, social security number, contact information, other identifiers) are not recorded, do not require ethical approval. Still, the study was conducted in compliance with the Helsinki Declaration in its latest form and good clinical practice guidelines and followed the rules for informed consent. Informed consent was obtained from all study participants. Written consent was obtained from GPs by CS, and then the GPs were anonymized, identifiers altered, and data that could identify the clinic were encrypted. All data were stored and processed per the requirements of European General Data Protection Regulation. The study owner is responsible for all study activities including that data collection comply with the Danish law on handling of personal data. The study owner is responsible that the identities of the participants are fully anonymized. All study participants were informed about the study before participation via written material or oral explanation. The written material was tailored to general practitioners to ensure it was understandable and relevant. The information material was designed using study information and consent form templates from the National Committee on Health Research Ethics in Denmark, supplemented with guidance from the University of Copenhagen.
: Not applicable.
: The authors declare no competing interests.